SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-011753
Filing Date
2020-08-05
Accepted
2020-08-05 13:46:11
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vcel-20200630.htm   iXBRL 10-Q 1658855
2 EX-31.1 CEO CERTIFICATION ex311ceocertificationq.htm EX-31.1 16844
3 EX-31.2 CFO CERTIFICATION ex312cfocertificationq.htm EX-31.2 15421
4 EX-32.1 CEO SOX CERTIFICATION ex321ceosoxcertificati.htm EX-32.1 8976
5 EX-32.2 CFO SOX CERTIFICATION ex322cfosoxcertificati.htm EX-32.2 8961
  Complete submission text file 0001628280-20-011753.txt   6564433

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcel-20200630.xsd EX-101.SCH 29288
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vcel-20200630_cal.xml EX-101.CAL 63290
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcel-20200630_def.xml EX-101.DEF 150242
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcel-20200630_lab.xml EX-101.LAB 439985
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcel-20200630_pre.xml EX-101.PRE 269537
11 EXTRACTED XBRL INSTANCE DOCUMENT vcel-20200630_htm.xml XML 1347288
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

IRS No.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35280 | Film No.: 201076671
SIC: 2836 Biological Products, (No Diagnostic Substances)